PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ …
Last week PANTHERx participated in the 2019 Asembia Specialty Pharmacy Summit in Las Vegas, NV, where we met with partners, announced strategic collaborations, unveiled the new PANTHERx brand, and shared …
We are excited to announce that PANTHERx Specialty Pharmacy has been selected as a finalist in the category of Retail/Independent/Hospital and Health System Specialty Pharmacies for the 2019 Specialty Pharmacy …
PANTHERx Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, unveiled a new, sophisticated and modern brand identity today while simultaneously announcing a new, state-of-the-art third location. This past year. PANTHERx continued …
The Press Release that follows was published by Cardinal Health to formally announce the collaboration between PANTHERx Specialty Pharmacy and Cardinal Health. To read the official press release, click here: …
PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announces the expansion of its oncology franchise to include Precision Medicine. PANTHERx’s focus on rare and devastating diseases now extends to the …
Last week, PANTHERx Specialty Pharmacy hosted the University of Pittsburgh’s Student Association of Specialty Pharmacy (SASP). The University of Pittsburgh’s SASP chapter was founded earlier this year with the help …
PANTHERx Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, announced the addition of William T. Valenta, Jr., MBA to its executive leadership team as Senior Vice President and Head of Business. …
PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announced the addition of industry veteran Susan Faust to its executive leadership team as Senior Vice President and Head of Markets. In …
PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announced that it has been selected by Insmed Incorporated to distribute ARIKAYCE® (amikacin liposome inhalation suspension), the first and only therapy specifically …
